Assessment of the binding mechanism of ergothioneine to human serum albumin: Multi-spectroscopy, molecular docking and molecular dynamic simulation.
Abstract
Ergothioneine (EGT) has attracted great attention due to its extremely potent antioxidant properties, universally acknowledged as 'longevity vitamin'. In order to comprehensive understanding of its pharmacodynamics and pharmacokinetics, the binding mechanism of EGT with human serum albumin (HSA) was clarified by cutting-edged multi-spectroscopic approaches and in silico molecular docking coupled with molecular dynamic simulation. Our fluorescence quenching results revealed that the binding of EGT to HSA was in a static quenching mode validated by the descending Stern-Volmer constant (K
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the binding mechanism of ergothioneine, which is posited as a 'longevity vitamin' due to its antioxidant properties. While it touches on a compound associated with longevity, the focus is primarily on the binding interactions with human serum albumin rather than directly addressing mechanisms of aging or lifespan extension. The findings may contribute to understanding the pharmacodynamics of ergothioneine, but they do not significantly advance the field of longevity research or address root causes of aging. Thus, the impact is rated as a solid but limited contribution.
Author of this paper? Send a correction.